Status:
COMPLETED
Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population
Lead Sponsor:
Ferring Pharmaceuticals
Collaborating Sponsors:
DeltaMed
Conditions:
Bowel Cleansing
Eligibility:
All Genders
Brief Summary
High-quality bowel preparation plays an important role in ensuring a safe and successful X-ray examination, endoscopy or some kinds of bowel surgeries. Inadequate bowel preparation may lead to incompl...
Eligibility Criteria
Inclusion
- Patients who have been prescribed Ferring Compound Sodium Picosulfate Granules
- Agree to participate in this study and sign the informed consent form (ICF).
Exclusion
- \- Patients who are enrolled in other on-going studies, which prohibit any participation in this non-interventional study.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04852120
Start Date
April 1 2021
End Date
December 31 2022
Last Update
February 26 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Ferring Investigational Site
Beijing, China
2
Ferring Investigational Site
Dalian, China
3
Ferring Investigational Site
Fuzhou, China
4
Ferring Investigational Site
Jingdezhen, China